Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesis - Liss - 2021 - Journal of Internal Medicine - Wiley Online Library
NIA-Funded Active Alzheimer's and Related Dementias Clinical Trials and Studies | National Institute on Aging
Frontiers | Early Stages of Alzheimer's Disease: Evolving the Care Team for Optimal Patient Management | Neurology
Biology | Free Full-Text | Clinical Features of Parkinson's Disease: The Evolution of Critical Symptoms | HTML
DIAGNOSIS OF EARLY ALZHEIMER'S DISEASE: CLINICAL PRACTICE IN 2021 • The Journal of Prevention of Alzheimer's Disease
Diagnosis of Alzheimer's disease utilizing amyloid and tau as fluid biomarkers | Experimental & Molecular Medicine
Clinically accurate diagnosis of Alzheimer's disease via multiplexed sensing of core biomarkers in human plasma | Nature Communications
Biology | Free Full-Text | Clinical Features of Parkinson's Disease: The Evolution of Critical Symptoms | HTML
Shaping a data-driven era in dementia care pathway through computational neurology approaches | BMC Medicine | Full Text
Brain connectivity in neurodegenerative diseases—from phenotype to proteinopathy | Nature Reviews Neurology
University College London/University of Gothenburg PhD course “Biomarkers in neurodegenerative diseases” 2019—course organisation | Alzheimer's Research & Therapy | Full Text
Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid* - Molecular & Cellular Proteomics
Benefits, pitfalls, and future design of population-based registers in neurodegenerative disease | Neurology
Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases - Mayo Clinic Proceedings
RETISPEC AND TORONTO MEMORY PROGRAM AWARDED GRANT TO LAUNCH INNOVATIVE EARLY DETECTION PROGRAM FOR ALZHEIMER'S IN TORONTO, CANADA
Neurodegenerative disease - Wikipedia
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment: Trends in Pharmacological Sciences
Blood-based biomarkers for Alzheimer's disease: towards clinical implementation - The Lancet Neurology
Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesis - Liss - 2021 - Journal of Internal Medicine - Wiley Online Library
Serum markers glial fibrillary acidic protein and neurofilament light for prognosis and monitoring in cognitively normal older people: a prospective memory clinic-based cohort study - The Lancet Healthy Longevity
Biomarkers for neurodegenerative diseases | Nature Medicine
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias - The Lancet Neurology
